G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)

G&E Herbal Biotechnology Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Feb 20, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	3,481	3,440	2,972	1,558	1,940	2,004
Market Cap Growth	-23.42%	15.73%	90.71%	-19.66%	-3.19%	1.55%
Enterprise Value	3,159	3,226	2,849	1,446	1,819	1,874
Last Close Price	59.00	57.72	49.87	26.15	32.55	33.62
PE Ratio	41.53	47.51	402.69	-	-	-
PS Ratio	16.49	18.96	46.00	63.43	68.71	114.15
PB Ratio	4.49	4.51	4.30	2.28	2.76	2.79
P/TBV Ratio	5.14	5.47	5.34	2.84	3.42	3.44
P/FCF Ratio	26.92	31.86	30.64	-	-	-
P/OCF Ratio	24.75	30.31	29.73	-	2515.89	-
EV/Sales Ratio	14.96	17.78	44.10	58.83	64.44	106.75
EV/EBITDA Ratio	30.59	35.83	191.43	-	-	-
EV/EBIT Ratio	33.83	39.98	519.39	-	-	-
EV/FCF Ratio	24.43	29.88	29.37	-	-	-
Debt / Equity Ratio	0.00	0.00	-	-	-	-
Debt / EBITDA Ratio	0.02	0.02	-	-	-	-
Debt / FCF Ratio	0.02	0.02	-	-	-	-
Asset Turnover	0.26	0.22	0.09	0.04	0.04	0.02
Inventory Turnover	1.80	1.55	1.14	0.81	1.07	1.38
Quick Ratio	3.39	2.77	2.25	13.14	15.04	10.63
Current Ratio	3.61	2.97	2.54	15.66	17.42	12.77
Return on Equity (ROE)	11.20%	9.96%	1.07%	-2.87%	-2.01%	-3.20%
Return on Assets (ROA)	7.09%	6.05%	0.46%	-1.74%	-1.34%	-2.41%
Return on Capital (ROIC)	7.78%	6.93%	0.50%	-1.76%	-1.36%	-2.46%
Return on Capital Employed (ROCE)	12.03%	10.55%	0.79%	-	-	-
Earnings Yield	2.41%	2.10%	0.25%	-1.28%	-0.74%	-1.17%
FCF Yield	3.71%	3.14%	3.26%	-0.70%	-0.22%	-1.29%
Dividend Yield	0.91%	0.93%	-	-	-	-
Buyback Yield / Dilution	-0.10%	-0.08%	-	-	-	-
Total Shareholder Return	0.81%	0.85%	-	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.